Establishment of a human pancreatic adenocarcinoma cell line (PSN-1) with amplifications of both c-myc and activated c-Ki-ras by a point mutation.
about
P1343
Protein farnesyltransferase inhibitors block the growth of ras-dependent tumors in nude miceIsolation of genes specifically expressed in flat revertant cells derived from activated ras-transformed NIH 3T3 cells by treatment with azatyrosineOncolytic virus therapy for pancreatic cancer using the adenovirus library displaying random peptides on the fiber knob.Orthotopic models of human pancreatic cancer.Cten is targeted by Kras signalling to regulate cell motility in the colon and pancreas.Targeting the K-Ras--JNK axis eliminates cancer stem-like cells and prevents pancreatic tumor formation.Development of peritoneal tumor-targeting vector by in vivo screening with a random peptide-displaying adenovirus library.Production of endothelin-1 and thrombomodulin by human pancreatic cancer cellsThe detection of K-ras mutations in colorectal cancer using the amplification-refractory mutation system.Measles virus selectively blind to signaling lymphocyte activity molecule has oncolytic efficacy against nectin-4-expressing pancreatic cancer cells.Polyetheylenimine-polyplexes of Spiegelmer NOX-A50 directed against intracellular high mobility group protein A1 (HMGA1) reduce tumor growth in vivo.Concurrent mutations in two different ras genes in acute myelocytic leukemias.Radicicol leads to selective depletion of Raf kinase and disrupts K-Ras-activated aberrant signaling pathway.Establishment and characterization of human pancreatic cancer cell lines in tissue culture and in nude mice.Ki-ras activation in pancreatic carcinomas of Syrian hamsters induced by N-nitrosobis(2-hydroxypropyl)amine.Antitumor activity of gemcitabine against high-grade meningioma in vitro and in vivo.Neoplastic transformation of rat colon epithelial cells by expression of activated human K-ras.Comparison of K-ras oncogene activation in pancreatic duct carcinomas and cholangiocarcinomas induced in hamsters by N-nitrosobis(2-hydroxypropyl)amine.
P2860
Q28369454-C1A77FC9-36C7-4656-8B3A-64AEEEAB6C42Q33216759-F6F78060-08F7-4D9D-BC35-AF3F59E106D6Q33410245-ADA62637-98FD-4D0D-AAA4-2FCE5A3C73C8Q33692987-5685EC3D-11BE-4430-B780-7DFA519B30D2Q33940978-2F0EC023-B8EE-469E-93B5-301B6829A521Q34104152-76AB970D-7BCE-485F-AC07-3C464086F230Q34429367-173C2FB1-C6EA-4659-BEE6-BF0AFD6F8B14Q35979094-A9C73401-53AF-42D8-9E43-600E9CF96F47Q36292380-EDBD70E6-43F5-4D8A-A0FB-59678602676EQ37462626-12D50195-7813-4ED2-B06E-E0B6B207866EQ38339945-719A6F6B-F40D-43A2-8306-0E91A39D930EQ40389164-C2E15DA3-7040-4EA8-B838-50E30575017FQ41066094-2EFF42E6-4B12-4123-96BB-5D3294BCE02AQ41719680-CDF0B116-3682-4240-A1D1-FC947132B5D8Q41989958-2FF74919-FCCF-4AF3-AA72-80BEB0E85C03Q47122159-03BC1E07-1C76-4D5A-9C48-C9561BDB646BQ47690613-D6994951-6E2B-456B-93CD-31CA02E477F6Q55025294-95BABF8D-1C6A-4A02-BD28-08177DD5EB74
P2860
Establishment of a human pancreatic adenocarcinoma cell line (PSN-1) with amplifications of both c-myc and activated c-Ki-ras by a point mutation.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年学术文章
@wuu
1986年学术文章
@zh
1986年学术文章
@zh-cn
1986年学术文章
@zh-hans
1986年学术文章
@zh-my
1986年学术文章
@zh-sg
1986年學術文章
@yue
1986年學術文章
@zh-hant
name
Establishment of a human pancr ...... c-Ki-ras by a point mutation.
@en
Establishment of a human pancreatic adenocarcinoma cell line
@nl
type
label
Establishment of a human pancr ...... c-Ki-ras by a point mutation.
@en
Establishment of a human pancreatic adenocarcinoma cell line
@nl
prefLabel
Establishment of a human pancr ...... c-Ki-ras by a point mutation.
@en
Establishment of a human pancreatic adenocarcinoma cell line
@nl
P2093
P1476
Establishment of a human pancr ...... c-Ki-ras by a point mutation.
@en
P2093
P304
P356
10.1016/0006-291X(86)91072-7
P407
P4510
P577
1986-10-01T00:00:00Z